CR7720A - 2-HYDROXI-1,3- DIAMINOALCANE OIL - Google Patents

2-HYDROXI-1,3- DIAMINOALCANE OIL

Info

Publication number
CR7720A
CR7720A CR7720A CR7720A CR7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A CR 7720 A CR7720 A CR 7720A
Authority
CR
Costa Rica
Prior art keywords
diaminoalcane
hydroxi
oil
compounds
disclosed
Prior art date
Application number
CR7720A
Other languages
Spanish (es)
Inventor
Maillard Michel
T Baldwin Eric
P Beck James
Hughes Robert
Varghese John
R Pulley Shon
Tenbrink Ruth
Original Assignee
Elan Pharm Inc
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharm Inc, Upjohn Co filed Critical Elan Pharm Inc
Publication of CR7720A publication Critical patent/CR7720A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se divulgan compuestos de la Formula I. Donde las variables Z,X, R15, R2, R3, Rc son definidas aqui. Los compuestos divulgados aqui son inhibidores de la enzima beta secretasa y por lo tanto, son utiles para el tratamiento de la enfermedad del Alzheimer y otras enfermedades caracterizadas por la deposicion del peptido A beta en un mamifero.Compounds of Formula I are disclosed. Where the variables Z, X, R15, R2, R3, Rc are defined herein. The compounds disclosed herein are inhibitors of the beta secretase enzyme and are therefore useful for the treatment of Alzheimer's disease and other diseases characterized by the deposition of the beta A peptide in a mammal.

CR7720A 2002-09-10 2005-03-09 2-HYDROXI-1,3- DIAMINOALCANE OIL CR7720A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40945302P 2002-09-10 2002-09-10

Publications (1)

Publication Number Publication Date
CR7720A true CR7720A (en) 2005-07-14

Family

ID=35353421

Family Applications (1)

Application Number Title Priority Date Filing Date
CR7720A CR7720A (en) 2002-09-10 2005-03-09 2-HYDROXI-1,3- DIAMINOALCANE OIL

Country Status (5)

Country Link
CN (1) CN100384824C (en)
AP (1) AP2005003247A0 (en)
CR (1) CR7720A (en)
TN (1) TNSN05067A1 (en)
ZA (1) ZA200501991B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010030538A1 (en) * 2010-06-25 2011-12-29 Bayer Schering Pharma Aktiengesellschaft 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments
DE102011087987A1 (en) * 2011-12-08 2013-06-13 Bayer Intellectual Property Gmbh 6,7-Dihydro-5H-benzo [7] annulene derivatives, process for their preparation, pharmaceutical preparations containing them and their use for the preparation of medicaments
BR112019001407A2 (en) * 2016-07-29 2019-07-09 Pgi Drug Discovery Llc compounds and compositions and uses thereof
CN109790079B (en) * 2016-07-29 2022-06-03 香港科技大学 C (sp) of organozinc reagents and heterocyclic (pseudo) halides3)-C(sp2) Cross-coupling reaction
JP7191085B2 (en) 2017-08-02 2022-12-16 サノビオン ファーマシューティカルズ インク Isochroman compounds and uses thereof
CN113189089B (en) * 2021-03-19 2022-05-17 四川轻化工大学 Ozone detection reagent and preparation device and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482947A (en) * 1990-11-19 1996-01-09 Talley; John J. Retroviral protease inhibitors
US6150416A (en) * 1997-02-04 2000-11-21 The Regents Of The University Of California Nanomolar, non-peptide inhibitors of cathepsin D

Also Published As

Publication number Publication date
CN1694870A (en) 2005-11-09
CN100384824C (en) 2008-04-30
ZA200501991B (en) 2006-01-25
TNSN05067A1 (en) 2007-05-14
AP2005003247A0 (en) 2005-03-31

Similar Documents

Publication Publication Date Title
ECSP055696A (en) 2-HYDROXI-1, 3-DIAMINOALCAN OIL
UY28280A1 (en) 2- HYDROXI - 3- DIAMINOALCANOS DE BENZAMIDA
UY28101A1 (en) SUBSTITUTED UREAS AND USEFUL CARBAMATES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
UY28279A1 (en) FENACILO 2 -HIDROXI - 3 - DIAMINOALCANOS
CR7720A (en) 2-HYDROXI-1,3- DIAMINOALCANE OIL
AR025225A1 (en) PHYSYLOXAZOLIDINONES HETEROCICLIC BICYCLIC REPLACED ANTIBACTERIAL AND PHARMACEUTICAL COMPOSITIONS
UY27774A1 (en) METALOPROTEIN INHIBITORS OF TRIARIL-OXI-ARIL-ESPIROPIRIMIDINA-2,4,6-TRIONA
WO2005095326A3 (en) 2-amino- and 2-thio-substituted 1,3-diaminopropanes
UY26480A1 (en) N - (5 - (5 - ALKYL - 2 - OXAZOLYL) METHYL) THIO) - 2 - THIAZOLYL) - CYCLONE-DEPENDENT KINASE CARBOXAMIDE
ECSP055719A (en) TIAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
ECSP044992A (en) INHIBITORS OF THE ALQUÍN-ARIL FOSFODIESTERASA-4
NZ516599A (en) 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
UY28450A1 (en) 6 MEMBER HETEROARILE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS.
UY27338A1 (en) NEW DERIVATIVES OF SULPHONIC ACID
UY26481A1 (en) N - (5 - ((((5 - RENT - 2 - OXAZOLYL) METHYL) UNCLE) - 2 - THIAZOLYL) - CYCLONE-DEPENDENT KINASE CARBOXAMIDE.
FI970279A (en) Organic compounds
BR0306855A (en) Method for the treatment of cognitive disorders
UY27451A1 (en) 2,5-DIAMIDOINDOLES REPLACED AND ITS USE
GT200300066A (en) CYCLOPENTENE DERIVATIVES
UY28458A1 (en) OXAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
NO20053562L (en) Novel aminobenzophenone compounds
BR0314714A (en) Compounds for the treatment of alzheimer's disease
ATE359995T1 (en) AMINE 1,2 AND 1,3-DIOL COMPOUNDS AND THEIR USE IN THE TREATMENT OF ALZHEIMER'S DISEASE
PA8558901A1 (en) NEW HEXACICLIC COMPOUNDS
DE60210769D1 (en) USE OF BICYCLIC COMPOUNDS FOR THE TREATMENT OF ALZHEIMER

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)